We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 47

Supreme Court upholds passive euthanasia, issues guidelines on advance directives in landmark judgement
  • Khaitan & Co
  • India
  • March 14 2018

A Constitution Bench of the Hon’ble Supreme Court of India, comprising of the Hon’ble Chief Justice of India, Hon’ble Mr Justice A M Khanwilkar


DTAB appoints committee to review fixed dose combinations
  • Khaitan & Co
  • India
  • February 19 2018

The Drugs Technical Advisory Board (DTAB) has reportedly appointed an expert committee under Ms Nilima Shirsagar, retired dean of Mumbai's KEM


New year begins with further liberalisation of the FDI policy
  • Khaitan & Co
  • India
  • January 25 2018

The Department of Industrial Policy & Promotion (DIPP), on 23 January 2018, by way of Press Note No. 1 (2018 Series) (PN 1), notified certain


Supreme Court expands government’s powers to ban drugs under section 26a of the Drugs & Cosmetics act, 1940
  • Khaitan & Co
  • India
  • January 3 2018

On 10 March 2016, the Central Government issued 344 identically worded notifications (Notifications) prohibiting the manufacture, sale and


Guidelines for food recall
  • Khaitan & Co
  • India
  • December 12 2017

The Food Safety and Standards Authority of India (FSSAI) recently released guidelines (Guidelines) on food recall by food business operators (FBO


Amendments to the legal metrology (packaged commodities) rules, 2011
  • Khaitan & Co
  • India
  • July 5 2017

The purpose of the Legal Metrology (Packaged Commodities) Rules, 2011 (PCR) is to regulate pre-packaged commodities. Under the PCR, pre-packaged


Requirement of Bio-Equivalence Studies for Generic Drugs - a Step in the Right Direction
  • Khaitan & Co
  • India
  • April 25 2017

Access to affordable and safe medicines is the cornerstone of a vibrant public health framework. The cost of medicines substantially depends on the


New rules for medical devices
  • Khaitan & Co
  • India
  • February 7 2017

On 31 January 2017, the Ministry of Health and Family Welfare notified the Medical Devices Rules, 2017 (Rules) under the Drugs and Cosmetics


Delhi High Court strikes down notification dated 10 March 2016 issued by the government of India banning 344 fixed dose combination (FDC) drugs
  • Khaitan & Co
  • India
  • December 5 2016

A single judge of the Delhi High Court, Justice Rajiv Sahai Endlaw vide his Order and Judgment dated 1 December 2016 has struck down the notification


A respite to the pharmaceutical manufacturers - COMPAT sets aside CCI order
  • Khaitan & Co
  • India
  • May 12 2016

The Competition Appellate Tribunal (COMPAT) on 10 May 2016 has passed a landmark decision setting aside the Competition Commission of India's (CCI